Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
Authors
Keywords
Non-small cell lung cancer (NSCLC), Epidermal Growth Factor Receptor (EGFR), Immunohistochemistry, Fluorescence in Situ Hybridization, Antibody clones
Journal
Diagnostic Pathology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-16
DOI
10.1186/s13000-014-0165-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma
- (2014) Hye Ryun Kim et al. LUNG CANCER
- EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
- (2013) A. Warth et al. EUROPEAN RESPIRATORY JOURNAL
- Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma
- (2013) Shingo Soma et al. PATHOLOGY RESEARCH AND PRACTICE
- Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
- (2012) William D. Travis et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
- (2012) H Modjtahedi et al. BRITISH JOURNAL OF CANCER
- The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
- (2012) Arne Warth et al. JOURNAL OF CLINICAL ONCOLOGY
- IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma
- (2012) Hyun-Ju Lee et al. JOURNAL OF THORACIC IMAGING
- Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
- (2012) Susumu Kobayashi et al. Journal of Thoracic Oncology
- EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
- (2011) Robert Pirker et al. LANCET ONCOLOGY
- EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
- (2009) M Varella-Garcia et al. JOURNAL OF CLINICAL PATHOLOGY
- Assessment of Smoking Behaviors and Alcohol Use in the National Social Life, Health, and Aging Project
- (2009) M. L. Drum et al. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study
- (2009) Hyun Ju Lee et al. LUNG CANCER
- Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
- (2008) P Hofman et al. BRITISH JOURNAL OF CANCER
- Epidermal growth factor receptor immunohistochemistry
- (2008) Fred R. Hirsch et al. CANCER
- Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors
- (2008) K. D. Steffensen et al. CLINICAL CANCER RESEARCH
- EGFR Mutations in Lung Adenocarcinomas
- (2008) Allan R. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started